Literature DB >> 22069254

Persistent glucose transporter expression on pancreatic beta cells from longstanding type 1 diabetic individuals.

Ken T Coppieters1, Anna Wiberg, Natalie Amirian, Thomas W Kay, Matthias G von Herrath.   

Abstract

BACKGROUND: Recent reports have established the notion that many patients with longstanding type 1 diabetes (T1D) possess a remnant population of insulin-producing beta cells. It remains questionable, however, whether these surviving cells can physiologically sense and respond to glucose stimuli.
METHODS: Frozen pancreatic sections from non-diabetic donors (n=8), type 2 diabetic patients (n=4), islet autoantibody-positive non-diabetic patients (n=3), type 1 diabetic patients (n=10) and one case of gestational diabetes were obtained via the network for Pancreatic Organ Donors. All longstanding T1D samples were selected based on the detection of insulin-producing beta cells in the pancreas by immunohistochemistry. RNA was isolated from all sections followed by cDNA preparation and quantitative real-time polymerase chain reaction for insulin, glucose transporter 1 (GLUT1), GLUT2 and GLUT3. Finally, immunofluorescent staining was performed on consecutive sections for all four of these markers and a comparison was made between the expression of GLUT2 in humans versus NOD mice.
RESULTS: In contrast to islets from the most widely used T1D model, the NOD mouse, human islets predominantly express GLUT1 and, to a much lesser extent, GLUT3 on their surface instead of GLUT2. Relative expression levels of these receptors do not significantly change in the context of the various (pre-)diabetic conditions studied. Moreover, in both species preservation of GLUT expression was observed even under conditions of substantial leucocyte infiltration or decades of T1D duration.
CONCLUSIONS: These data suggest that despite being subjected to multiple years of physiological stress, the remaining beta-cell population in longstanding T1D patients retains a capacity to sense glucose via its GLUTs.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069254      PMCID: PMC5706467          DOI: 10.1002/dmrr.1246

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  31 in total

1.  Polymorphisms at the GLUT2 (beta-cell/liver) glucose transporter gene and non-insulin-dependent diabetes mellitus (NIDDM): analysis in affected pedigree members.

Authors:  M G Baroni; J C Alcolado; P Pozzilli; M G Cavallo; S R Li; D J Galton
Journal:  Clin Genet       Date:  1992-05       Impact factor: 4.438

2.  Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes.

Authors:  J J Meier; J C Lin; A E Butler; R Galasso; D S Martinez; P C Butler
Journal:  Diabetologia       Date:  2006-06-27       Impact factor: 10.122

3.  Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J C Alcolado; M G Baroni; S R Li
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

4.  Multiple restriction fragment length polymorphisms at the GLUT2 locus: GLUT2 haplotypes for genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Patel; G I Bell; J T Cook; R C Turner; J S Wainscoat
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

5.  Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.

Authors:  R Santer; R Schneppenheim; A Dombrowski; H Götze; B Steinmann; J Schaub
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

6.  Screening for insulitis in adult autoantibody-positive organ donors.

Authors:  Peter In't Veld; Dirk Lievens; Joeri De Grijse; Zhidong Ling; Bart Van der Auwera; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers
Journal:  Diabetes       Date:  2007-06-11       Impact factor: 9.461

7.  Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.

Authors:  Y Tanizawa; A C Riggs; K C Chiu; R C Janssen; D S Bell; R P Go; J M Roseman; R T Acton; M A Permutt
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

8.  Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Authors:  E H Liu; B J Digon; B Hirshberg; R Chang; B J Wood; Z Neeman; A Kam; R A Wesley; S M Polly; R M Hofmann; K I Rother; D M Harlan
Journal:  Diabetologia       Date:  2009-05-06       Impact factor: 10.122

9.  Comment on: Keenan et al. (2010) residual insulin production and pancreatic ß-Cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010;59:2846-2853.

Authors:  Kristina I Rother; David M Harlan
Journal:  Diabetes       Date:  2010-12       Impact factor: 9.461

10.  Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action.

Authors:  Inês Barroso; Jian'an Luan; Rita P S Middelberg; Anne-Helen Harding; Paul W Franks; Rupert W Jakes; D Clayton; Alan J Schafer; Stephen O'Rahilly; Nicholas J Wareham
Journal:  PLoS Biol       Date:  2003-10-13       Impact factor: 8.029

View more
  14 in total

Review 1.  Candidate genes expressed in human islets and their role in the pathogenesis of type 1 diabetes.

Authors:  Joachim Storling; Caroline Anna Brorsson
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

2.  Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients.

Authors:  Shiva Reddy; Nina Zeng; Hussam Al-Diery; Doran Jung; Clifton Yeu; Maximilian O Joret; Mervyn J Merrilees; Fiona Wu
Journal:  Diabetologia       Date:  2015-02-17       Impact factor: 10.122

3.  Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.

Authors:  Cristina M Fernández-Díaz; Beatriz Merino; José F López-Acosta; Pilar Cidad; Miguel A de la Fuente; Carmen D Lobatón; Alfredo Moreno; Malcolm A Leissring; Germán Perdomo; Irene Cózar-Castellano
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-03       Impact factor: 4.310

4.  Insulin-positive, Glut2-low cells present within mouse pancreas exhibit lineage plasticity and are enriched within extra-islet endocrine cell clusters.

Authors:  Christine A Beamish; Brenda J Strutt; Edith J Arany; David J Hill
Journal:  Islets       Date:  2016-03-24       Impact factor: 2.694

5.  Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase.

Authors:  Teresa Rodriguez-Calvo; Jessica S Suwandi; Natalie Amirian; Jose Zapardiel-Gonzalo; Florence Anquetil; Somayeh Sabouri; Matthias G von Herrath
Journal:  J Histochem Cytochem       Date:  2015-08       Impact factor: 2.479

Review 6.  New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.

Authors:  Alberto Pugliese; Francesco Vendrame; Helena Reijonen; Mark A Atkinson; Martha Campbell-Thompson; George W Burke
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

Review 7.  Insulitis in the pathogenesis of type 1 diabetes.

Authors:  Alberto Pugliese
Journal:  Pediatr Diabetes       Date:  2016-07       Impact factor: 4.866

Review 8.  Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.

Authors:  Chunguang Chen; Christian M Cohrs; Julia Stertmann; Robert Bozsak; Stephan Speier
Journal:  Mol Metab       Date:  2017-07-08       Impact factor: 7.422

Review 9.  Redox homeostasis in pancreatic β cells.

Authors:  Petr Ježek; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Oxid Med Cell Longev       Date:  2012-12-13       Impact factor: 6.543

Review 10.  The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings.

Authors:  Alberto Pugliese; Mingder Yang; Irina Kusmarteva; Tiffany Heiple; Francesco Vendrame; Clive Wasserfall; Patrick Rowe; Jayne M Moraski; Suzanne Ball; Les Jebson; Desmond A Schatz; Roberto Gianani; George W Burke; Concepcion Nierras; Teo Staeva; John S Kaddis; Martha Campbell-Thompson; Mark A Atkinson
Journal:  Pediatr Diabetes       Date:  2013-12-10       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.